Impact on Participation and Autonomy — Measuring Handicap Across Life Roles
Impact on Participation and Autonomy (IPA) · Also known as: IPA, IPA-Scale
The Impact on Participation and Autonomy (IPA) scale is a validated, patient-centered measure designed to quantify how chronic conditions or disabilities affect an individual's autonomy and participation in five key life domains: autonomy, mobility, occupation, social relations, and recreation. Developed in the Netherlands by Cardol and colleagues, it operationalizes the WHO handicap concept (now called 'participation restriction') and is widely used in rehabilitation, chronic disease management, and policy evaluation across Europe.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
IPA is indicated for (1) chronic disease management outcome tracking (MS, stroke, spinal cord injury, arthritis, COPD, chronic pain); (2) rehabilitation program evaluation (inpatient, outpatient, day program); (3) aging/geriatric assessment (impact of age-related conditions on life roles); (4) policy and health economics (measuring handicap for resource allocation, disability determination); (5) clinical trials in diseases with emphasis on participation/quality-of-life outcomes. Validated in adult populations; pediatric version exists but is less common. Strength: explicitly addresses participation and autonomy (ICF categories) rather than impairment or activity limitation alone. Can be administered via self-report or proxy (caregiver/clinician), enabling assessment in cognitively impaired or severely disabled populations.
Strengths & limitations
- Comprehensive coverage of life roles: five domains (autonomy, mobility, occupation, social, recreation) capture the full spectrum of participation, not just mobility or cognition.
- Explicit 'not applicable' option: avoids forced negative responses for people to whom a domain (e.g., work) does not apply, increasing measurement accuracy.
- Validated proxy version: enables assessment in cognitively impaired, non-communicative, or severely disabled individuals; strong proxy-self agreement (r 0.70–0.85).
- Patient-centered perspective: measures impact from the individual's viewpoint, not clinician judgment or objective impairment severity.
- Practical length: 32 items, ~10–15 minutes, no complex scoring, feasible in routine practice.
- Sensitivity to participation change: responsive to rehabilitation interventions in MS, SCI, arthritis; MCID typically 10–15 points total or 3–5 per domain.
- Cross-cultural validation: translated to 10+ languages (Dutch, English, German, Spanish, French, Italian, etc.) with acceptable psychometrics.
- Domain relevance: 'Occupation' may be inapplicable to retirees or students; 'Recreation' assumes access to leisure resources. In very resource-limited settings, some domains lose meaning.
- Proxy validity: while proxy versions are validated, disagreement with self-report occurs (average r 0.65–0.75), particularly on subjective domains like social relations. Use self-report as gold standard when cognitively capable.
- Floor and ceiling effects: in very high-functioning populations, many may score 0–10 (floor); in severely disabled (e.g., late-stage MS), may score >100 (ceiling).
- Context sensitivity: a person's IPA score is heavily influenced by social support, economic resources, and environmental accessibility, not just impairment. Same diagnosis can yield very different IPA scores based on socioeconomic context.
- Limited normative data: while validated in Europe, population norms are less extensive in North America, Asia, or other regions; comparison to literature means is needed.
- No item bank for short forms: while shorter versions have been created, no validated short form (like WHODAS-12) is widely standardized; most researchers use full 32-item version.
Frequently asked
What is the difference between IPA and WHODAS 2.0?
Both measure participation/functioning, but with different emphases. WHODAS measures functional limitation (difficulty with tasks like walking, self-care, cognition, social interaction) using structured domains from the ICF. IPA measures handicap/participation restriction (impact on actual life roles like work, family, recreation) and is more patient-centric. WHODAS is universal and condition-agnostic; IPA is more detailed on social/occupational participation but assumes a chronic disease context. In rehabilitation, IPA is more commonly used; WHODAS is more common in epidemiology and global health.
Can IPA be used in acute stroke or TBI?
IPA is not recommended for acute phase (0–3 months) when recovery is rapidly changing and participation opportunities are limited. It is most valid in chronic phase (6+ months) when a new functional baseline has been established. For acute outcome measurement, use acute-phase measures (FIM, NIHSS, GCS). IPA is valuable for 6-month, 1-year, and longer-term follow-up in stroke and TBI.
How should I score items marked 'not applicable'?
Do not score them (do not count as 0). Omit them from the dimension sum. If a person says 'not applicable' to work-related items because they are retired, those items are not part of their valid score. Document how many items per dimension are NA. If >30% of items in a dimension are NA, that dimension may not be interpretable for that person.
What is a clinically meaningful change in IPA?
Approximately 10–15 points on total IPA score, or 3–5 points per dimension. However, this varies by condition and population. In MS with active rehabilitation, changes of 15–20 points total are not uncommon over 3–6 months; in stable chronic disease, smaller changes (5–10) may be meaningful.
Is there a short form of IPA?
No validated short form is widely standardized. Researchers have developed 16-item or 20-item versions, but these are not in common use. The original 32-item version is the gold standard. However, if feasibility is critical, some institutions use subscale selection (e.g., only Autonomy + Occupation + Social, n=20) with acknowledgment of reduced comprehensiveness.
Can IPA be used in proxy respondents (caregivers, clinicians)?
Yes. A validated proxy version exists; caregiver or clinician report is acceptable and useful in cognitively impaired individuals. However, proxy and self-report average disagreement (r 0.70–0.75). Self-report is preferred when cognitively capable. Always note whether the score is self- or proxy-report.
How long does IPA take to administer?
10–15 minutes in an interview format, 8–12 minutes for self-completion. In cognitively impaired or very disabled individuals, 15–20 minutes may be needed for clarification of questions.
Is IPA free to use?
Yes, IPA is in the public domain. The instrument may be used without license fees. Always cite the original Cardol et al. (2001) source and, if using a translated version, acknowledge the translation developers.
Sources
- Cardol, M., de Haan, R. J., de Jong, B. A., van den Bos, G. A., & de Groot, I. J. (2001). Psychometric properties of the Impact on Participation and Autonomy questionnaire. Archives of Physical Medicine and Rehabilitation, 82(2), 210–216. link ↗
- Cardol, M., de Haan, R. J., van den Bos, G. A., de Jong, B. A., & de Groot, I. J. (2002). The development of a handicap assessment questionnaire: The Impact on Participation and Autonomy (IPA). Clinical Rehabilitation, 13(6), 411–419. link ↗
How to cite this page
ScholarGate. (2026, June 3). Impact on Participation and Autonomy (IPA). ScholarGate. https://scholargate.app/en/rehabilitation-science/impact-participation-autonomy
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Assessment of Life HabitsRehabilitation Science↔ compare
- Community Integration QuestionnaireRehabilitation Science↔ compare
- Participation Measure for Post-Acute CareRehabilitation Science↔ compare
- Participation ScaleRehabilitation Science↔ compare
- WHODAS 2.0Rehabilitation Science↔ compare